Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. In a Nature Communications paper published today, researchers reveal for the first time that the number of mitochondria in a cell is, in great part, associated with how the […]Continue Reading ...
Unlike the three most common forms of breast cancer, triple negative breast cancer has no currently approved targeted therapies for treatment. That was one of the reasons it was chosen as a disease area of focus for the Indiana University Precision Health Grand Challenge initiative, aimed to research and develop better treatments, cures or preventions, […]Continue Reading ...
Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators. The study, published March 22 in the print issue of Science, shows how high-fructose corn syrup fuels the growth of colon tumors in these […]Continue Reading ...
This month’s edition of Drug Discovery Today, Editor’s Choice returns to more familiar ground from last month’s excursion into regulatory issues, with 3 excellent articles on various aspects of drug discovery targeted at the treatment of cancer. The war on cancer has been a constant battle since the early 1970s as championed by Senator […]Continue Reading ...
Ludwig Cancer Research released today the full breadth of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Ga., March 29 – April 3, 2019. Research conducted by more than 75 Ludwig scientists will be shared in plenary sessions, major symposiums, education sessions, poster […]Continue Reading ...
FINDINGS Researchers from UCLA’s Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world’s deadliest cancers. The combination approach uses one drug that inhibits the process — known as lysosome — that allows cancer cells to recycle essential nutrients to […]Continue Reading ...
Researchers at the University of Milan have predicted that death rates from breast cancer will fall this year in all European Union (EU) countries, with the exception of Poland. Shutterstock | New Africa According to annual predictions by Carlo La Vecchia and colleagues, death rates from breast cancer will fall by almost nine percent across […]Continue Reading ...
Like many other patients who have overcome cancer, breast cancer survivors live in fear of relapse. Now, researchers have developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of the journal Nature. The new test […]Continue Reading ...
By any measure, lung cancer patients have it rough. But Maryland resident and special education teacher Montessa Lee has been through a particularly arduous ordeal. In September 2006, she experienced pain in her rib cage and sought medical care. Told she had inflammation, she was given medicine for her pain. But the pain returned. At […]Continue Reading ...
Spencer Hoover, vice president and executive director of the Henry Ford Cancer Institute, is co-author of a manuscript published in the Journal of Oncology Practice aimed at establishing best practices to promote diversity in clinical trials. In-depth interviews were conducted with leaders from U.S. cancer centers with above average recruitment of racial and ethnic minority […]Continue Reading ...
City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research (AACR) annual meeting from March 29 through April 3 in Atlanta. More than 22,500 […]Continue Reading ...
In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which […]Continue Reading ...
South San Francisco, CA — March 18, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of adults with extensive-stage small cell lung cancer (ES-SCLC). […]Continue Reading ...
A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing. The Cancer Research UK and Wellcome Trust funded study, published in the journal Cancer Cell, showed that the drugs, called PARG inhibitors, can kill ovarian cancer cells by targeting weaknesses […]Continue Reading ...
By conjuring the spell “Lumos!” wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program developed by the Translational Genomics Research Institute (TGen), “light up” cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their […]Continue Reading ...
- Breast Density Categorization Varies With Screening Modality
- Researchers explore link between metal exposure and Parkinson’s symptoms
- Around one in hundred people has autism spectrum condition in China
- Research paves way for new standard of care to improve heart’s pump function
- Exposure to HIV virus, antiretroviral therapy before birth linked to obesity and asthma-like symptoms
- Transgender men preserve their fertility potential after one year of testosterone therapy
- Tighter Blood Pressure Control May Prevent Brain Lesions
- A reward now or later? Exploring impulsivity in Parkinson’s disease patients
- Financial incentives fail to increase completion rates of colorectal cancer screening tests mailed to patients
- New research program launched to highlight sexual harassment in academia
- Hemoglobin A1c blood test does not detect diabetes in most patients, shows study
- Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics
- DWK Life Sciences launches KIMBLE GLS 80 Media Bottle and Multiport Cap System
- New study aims to reduce online sexual exploitation of children
- Want healthier eating habits? Start with a workout
- New approach to prescribing antibiotics could curb resistance
- Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
- Prenatal DHA prevents blood-pressure increase from obesity during childhood
- Combined immunosuppression may be effective, safe in treating older patients with Crohn’s disease
- GSK sells health drinks arm, buys US cancer treatment firm